0,912  0,003  Cardiovascular analeptic
0,750  0,006  CYP1A2 substrate
0,723  0,010  GST A substrate
0,688  0,005  Urologic disorders treatment
0,683  0,003  Calcium channel L-type activator
0,678  0,003  FMO1 substrate
0,636  0,008  Eye irritation, high
0,637  0,014  Respiratory analeptic
0,621  0,005  Urinary incontinence treatment
0,617  0,004  Alpha-N-acetylglucosaminidase inhibitor
0,637  0,025  CYP3A4 substrate
0,630  0,022  Cyclophilin D inhibitor
0,630  0,022  Antidiabetic
0,623  0,016  Aldehyde oxidase inhibitor
0,620  0,022  TNF expression inhibitor
0,603  0,013  Analeptic
0,590  0,002  Ferrochelatase inhibitor
0,591  0,005  Peroxidase inhibitor
0,584  0,004  Acaricide
0,592  0,014  CTGF expression inhibitor
0,571  0,005  Sulfotransferase substrate
0,578  0,014  5 Hydroxytryptamine release inhibitor
0,562  0,003  SULT1A3 substrate
0,568  0,018  CYP2C19 substrate
0,571  0,024  Antiobesity
0,552  0,027  CYP2C9 substrate
0,535  0,011  Skin irritative effect
0,536  0,012  Cardiodepressant
0,540  0,021  5 Hydroxytryptamine release stimulant
0,536  0,021  Carcinogenic
0,540  0,027  Cholesterol antagonist
0,533  0,023  Antihypercholesterolemic
0,516  0,006  Flavin-containing monooxygenase substrate
0,529  0,020  Sensitization
0,529  0,025  Antipruritic, allergic
0,509  0,004  Bronchodilator
0,514  0,012  Chronic obstructive pulmonary disease treatment
0,524  0,028  Antiasthmatic
0,516  0,024  Histamine release inhibitor
0,538  0,047  Caspase 9 stimulant
0,512  0,025  Vasodilator, peripheral
0,507  0,022  Radioprotector
0,499  0,015  Hypoglycemic
0,503  0,031  Toll-Like receptor 7 agonist
0,497  0,025  CYP2D6 substrate
0,477  0,007  Calcium channel activator
0,493  0,024  Spasmolytic
0,500  0,032  Toll-Like receptor agonist
0,477  0,014  UGT2B4 substrate
0,464  0,012  Radiosensitizer
0,482  0,036  Atherosclerosis treatment
0,450  0,006  GST M1-1 substrate
0,476  0,033  GABA C receptor rho-3 antagonist
0,454  0,026  Cytostatic
0,476  0,048  Antibacterial
0,446  0,025  NOS2 expression inhibitor
0,464  0,052  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,438  0,028  UGT1A9 substrate
0,411  0,005  Carcinogenic, group 1
0,424  0,021  Hypolipemic
0,404  0,003  Phenylalanine 4-hydroxylase inhibitor
0,412  0,012  5 Hydroxytryptamine uptake stimulant
0,412  0,014  Abortion inducer
0,404  0,009  Antiischemic, cerebral
0,409  0,014  UGT1A4 substrate
0,396  0,007  Peptidyltransferase inhibitor
0,437  0,051  Immunosuppressant
0,420  0,034  Lipoprotein disorders treatment
0,411  0,029  Mutagenic
0,388  0,006  CNS active muscle relaxant
0,390  0,009  GST P1-1 substrate
0,390  0,010  Pneumotoxic
0,399  0,019  Interleukin agonist
0,426  0,047  Ulceration
0,395  0,017  Anesthetic general
0,414  0,041  Antifungal
0,398  0,025  Antihypoxic
0,389  0,021  FMO3 substrate
0,381  0,013  UGT2B7 substrate
0,410  0,043  Teratogen
0,406  0,041  Embryotoxic
0,393  0,032  Interleukin antagonist
0,363  0,004  Carcinogenic, group 2A
0,363  0,004  Triose-phosphate isomerase inhibitor
0,385  0,027  Antidiabetic symptomatic
0,377  0,023  UDP-glucuronosyltransferase substrate
0,363  0,009  Antiparkinsonian, tremor relieving
0,381  0,028  UGT1A6 substrate
0,372  0,019  Antiparkinsonian, rigidity relieving
0,367  0,016  Antiseptic
0,361  0,014  Tyrosine 3 hydroxylase inhibitor
0,363  0,016  Antihypotensive
0,357  0,011  UGT2B15 substrate
0,351  0,005  Excitatory amino acid transporter EAAC1 inhibitor
0,369  0,032  Antiglaucomic
0,383  0,047  ICAM1 expression inhibitor
0,357  0,022  UGT1A1 substrate
0,378  0,043  Vasodilator, coronary
0,346  0,014  Genotoxic
0,366  0,039  Interleukin 2 agonist
0,330  0,004  Alcohol oxidase inhibitor
0,351  0,025  Cyclic AMP phosphodiesterase inhibitor
0,327  0,005  Antispirochetal
0,329  0,008  UGT2B9 substrate
0,331  0,016  Hair growth stimulant
0,319  0,004  SULT1A1 substrate
0,330  0,016  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,321  0,008  Nitric-oxide synthase stimulant
0,323  0,011  Glutathione S-transferase substrate
0,316  0,005  Choleretic
0,314  0,006  Antiemetic
0,320  0,018  Skeletal muscle relaxant
0,338  0,039  Antineoplastic (endocrine cancer)
0,337  0,039  Superoxide dismutase inhibitor
0,357  0,062  Antithrombotic
0,301  0,007  Adenylate kinase inhibitor
0,310  0,017  Amylase inhibitor
0,297  0,010  UDP-glucose 4-epimerase inhibitor
0,292  0,006  UGT2B10 substrate
0,306  0,021  Melanin inhibitor
0,289  0,004  Antirickettsial
0,313  0,029  Muscle relaxant
0,307  0,024  VCAM1 expression inhibitor
0,334  0,051  Sodium/bile acid cotransporter inhibitor
0,292  0,010  GABA C receptor agonist
0,302  0,021  Carcinogenic, group 3
0,349  0,068  Antiallergic
0,292  0,012  Succinate dehydrogenase inhibitor
0,283  0,004  Growth stimulant
0,293  0,014  Antidiarrheal
0,281  0,005  Electron transport complex I inhibitor
0,286  0,011  Cell wall synthesis inhibitor
0,339  0,065  Antihypertensive
0,308  0,037  Antihypertriglyceridemic
0,316  0,049  Cytotoxic
0,268  0,005  Photosensitizer
0,275  0,015  Antiadrenergic
0,313  0,053  Chemoprotective
0,272  0,015  Adrenaline antagonist
0,299  0,043  Psychostimulant
0,274  0,021  Protein kinase stimulant
0,322  0,069  Antidepressant
0,254  0,004  GST T1-1 substrate
0,295  0,045  DNA synthesis inhibitor
0,268  0,021  Antiviral (West Nile virus)
0,252  0,007  Coagulant
0,272  0,027  CYP2B6 inhibitor
0,249  0,004  Glutamate decarboxylase inhibitor
0,247  0,003  Antidote, mercury
0,257  0,014  Antitussive
0,260  0,019  NADPH oxidase inhibitor
0,269  0,029  Neurotrophic factor enhancer
0,263  0,025  Diabetic nephropathy treatment
0,265  0,027  Insulin sensitizer
0,265  0,027  UGT1A3 substrate
0,243  0,006  MAP3K9 inhibitor
0,276  0,039  Sedative
0,259  0,022  Allergic rhinitis treatment
0,244  0,009  Raynaud's phenomenon treatment
0,254  0,018  Renal failure treatment
0,249  0,014  VEGF expression inhibitor
0,268  0,033  Antimutagenic
0,338  0,105  Analgesic, non-opioid
0,244  0,011  UGT2B1 substrate
0,297  0,064  Antidiabetic (type 2)
0,243  0,010  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,286  0,057  Proliferative diseases treatment
0,233  0,005  Adenylate cyclase stimulant
0,260  0,032  Antipruritic, non-allergic
0,235  0,009  Porphobilinogen synthase inhibitor
0,233  0,006  HIV-1 integrase (Overall Integration) inhibitor
0,241  0,019  Antihyperlipoproteinemic
0,232  0,011  Cyclooxygenase 3 inhibitor
0,248  0,028  Muscular dystrophy treatment
0,239  0,022  Anesthetic local
0,236  0,020  Cholesterol synthesis inhibitor
0,299  0,083  AR expression inhibitor
0,272  0,056  Gastrin inhibitor
0,262  0,048  Fibrosis treatment
0,236  0,022  Cocaine dependence treatment
0,248  0,034  Antianorexic
0,322  0,109  CYP2C19 inhibitor
0,277  0,065  Antipyretic
0,213  0,010  Arylamine N-Acetyltransferase substrate
0,267  0,065  Antiprotozoal (Leishmania)
0,217  0,016  Antiprotozoal (Trichomonas)
0,210  0,009  Creatine kinase inhibitor
0,255  0,057  Antiulcerative
0,289  0,091  Mood disorders treatment
0,201  0,006  Toll-Like receptor 3 antagonist
0,206  0,012  Mucolytic
0,293  0,098  Transcription factor NF kappa B inhibitor
0,199  0,004  UGT2B11 substrate
0,224  0,030  Aldehyde oxidase substrate
0,272  0,079  Antiosteoporotic
0,202  0,009  Sphingomyelinase inhibitor
0,304  0,112  Calpain 2 inhibitor
0,196  0,004  Ca2+-transporting ATPase inhibitor
0,225  0,033  Interferon gamma antagonist
0,244  0,053  RNA-directed DNA polymerase inhibitor
0,278  0,087  Antiischemic
0,213  0,022  Arachidonic acid antagonist
0,197  0,007  Adrenaline agonist
0,209  0,020  Interleukin 4 antagonist
0,283  0,095  Bone diseases treatment
0,249  0,061  Antiparasitic
0,222  0,034  Anesthetic
0,195  0,007  Somatostatin 1 agonist
0,202  0,015  Catalase inhibitor
0,301  0,115  CYP2C9 inhibitor
0,240  0,054  Chemopreventive
0,195  0,011  NADH dehydrogenase inhibitor
0,268  0,085  Hypoxia-inducible factor 1 alpha inhibitor
0,193  0,011  Actinic keratosis treatment
0,186  0,005  Lanosterol 14 alpha demethylase inhibitor
0,201  0,020  Expectorant
0,270  0,089  Immunostimulant
0,194  0,014  GABA C receptor antagonist
0,198  0,019  Nav1.4 sodium channel blocker
0,204  0,027  GABA C receptor rho-2 antagonist
0,183  0,007  Biliverdin reductase inhibitor
0,264  0,090  Antiepileptic
0,178  0,004  Antiviral (Parainfluenza)
0,193  0,019  Anticataract
0,205  0,032  Phobic disorders treatment
0,347  0,175  Antiinflammatory
0,265  0,094  NOS3 expression inhibitor
0,178  0,008  Prostaglandin EP2 antagonist
0,212  0,042  Antiviral (Ebola)
0,264  0,095  Antipsoriatic
0,191  0,023  Antiviral (Poxvirus)
0,200  0,032  Antifungal enhancer
0,183  0,016  Antihelmintic (Fasciola)
0,173  0,008  Paget's disease treatment
0,173  0,008  Interleukin 5 antagonist
0,242  0,077  Acute neurologic disorders treatment
0,180  0,015  Chronic obstructive bronchitis treatment
0,191  0,027  Cystathionine beta-synthase inhibitor
0,260  0,097  Anxiolytic
0,171  0,009  Anabolic
0,189  0,028  Adenylate cyclase inhibitor
0,203  0,041  Antiacne
0,245  0,083  DNA damaging
0,247  0,086  Amyotrophic lateral sclerosis treatment
0,186  0,025  Carcinogenic, group 2B
0,225  0,064  Antialcoholic
0,186  0,027  Retinoprotector
0,202  0,043  Diuretic
0,178  0,020  Pregnane X receptor agonist
0,164  0,007  Glutamate release inhibitor
0,171  0,014  GABA C receptor rho-1 antagonist
0,196  0,040  Uterine stimulant
0,199  0,043  Phospholipase A2 inhibitor
0,232  0,077  Free radical scavenger
0,198  0,043  Acetylcholine M1 receptor antagonist
0,206  0,053  5 Hydroxytryptamine 3E antagonist
0,170  0,018  Calcium antagonist
0,232  0,081  Platelet antagonist
0,229  0,078  Neuropeptide Y2 antagonist
0,188  0,037  Mannose-6-phosphate isomerase inhibitor
0,160  0,010  Tocolytic
0,172  0,025  Menstruation disorders treatment
0,273  0,126  Stroke treatment
0,167  0,019  Antiviral (Influenza B)
0,173  0,026  Shock treatment
0,162  0,016  Phosphofructokinase-1 inhibitor
0,174  0,028  Aminopeptidase B inhibitor
0,169  0,024  Gastritis treatment
0,177  0,032  Movement disorders treatment
0,167  0,023  Antineoplastic, alkylator
0,159  0,014  Glutamate dehydrogenase inhibitor
0,148  0,005  Antiviral (Hepatitis A)
0,168  0,025  Antiprotozoal (Babesia)
0,165  0,023  HDL-cholesterol increasing
0,175  0,033  Antifungal (Cryptococcus)
0,192  0,050  Phospholipase C inhibitor
0,167  0,025  Carbonic anhydrase XV inhibitor
0,142  0,002  Sodium-dependent vitamin C transporter 2 inhibitor
0,150  0,011  Antifungal (Candida)
0,148  0,009  Acyl-CoA dehydrogenase inhibitor
0,142  0,004  Aconitate hydratase inhibitor
0,157  0,020  Urease inhibitor
0,241  0,105  Insulysin inhibitor
0,151  0,014  Keratolytic
0,166  0,030  Microtubule formation inhibitor
0,249  0,116  CYP3A4 inhibitor
0,158  0,026  Carbonic anhydrase III inhibitor
0,164  0,032  Antineoplastic antimetabolite
0,144  0,013  NAT1 substrate
0,238  0,108  Lipoxygenase inhibitor
0,143  0,012  Argininosuccinate synthase inhibitor
0,150  0,019  Electrolyte absorption antagonist
0,229  0,098  5 Hydroxytryptamine 1E antagonist
0,187  0,057  Irritable Bowel syndrome treatment
0,150  0,023  Androgen antagonist
0,141  0,014  Aminopeptidase I inhibitor
0,135  0,009  Purinergic P2X1 antagonist
0,148  0,022  Antifungal (Pneumocystis)
0,137  0,011  mTOR complex 2 inhibitor
0,231  0,105  CYP1A2 inhibitor
0,155  0,030  NAT2 substrate
0,163  0,037  Antibacterial (Helicobacter pylori)
0,215  0,090  Antiamyloidogenic
0,174  0,049  Aldose reductase substrate
0,133  0,009  Narcotic antagonist
0,146  0,022  Antiprotozoal (Toxoplasma)
0,154  0,030  Contraceptive female
0,131  0,007  Uterine relaxant
0,127  0,004  Antidote, organophosphates
0,139  0,016  Glutamate (mGluR7) agonist
0,163  0,040  Alkylator
0,180  0,058  ATPase inhibitor
0,146  0,024  DOPA decarboxylase inhibitor
0,156  0,034  Sphingosine 1-phosphate receptor 2 antagonist
0,148  0,028  Gastric antisecretory
0,134  0,013  Carbamoyl phosphate synthetase inhibitor
0,190  0,069  Antieczematic atopic
0,133  0,013  Leukotriene antagonist
0,214  0,094  Vasodilator
0,142  0,022  Cathepsin G inhibitor
0,124  0,005  Potassium channel Kv1.3 blocker
0,127  0,009  Beta 3 adrenoreceptor antagonist
0,219  0,102  Antioxidant
0,216  0,098  Calpain inhibitor
0,138  0,021  Histidine decarboxylase inhibitor
0,127  0,010  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,193  0,077  Non-steroidal antiinflammatory agent
0,150  0,034  Antischistosomal
0,121  0,006  Factor IXa inhibitor
0,143  0,028  Myasthenia Gravis treatment
0,166  0,052  Antiprotozoal (Coccidial)
0,139  0,024  Acetylcholine release stimulant
0,148  0,033  Alpha 2c adrenoreceptor antagonist
0,132  0,018  Ornithine decarboxylase inhibitor
0,223  0,110  Renal disease treatment
0,132  0,019  Alpha adrenoreceptor agonist
0,173  0,061  Cystic fibrosis treatment
0,122  0,010  Beta adrenoreceptor antagonist
0,115  0,003  Calcium-sensing receptor antagonist
0,123  0,011  Neuraminidase (influenza) inhibitor
0,119  0,008  GABA B receptor agonist
0,116  0,006  Gaucher disease treatment
0,116  0,006  Glutamate (mGluR6) antagonist
0,153  0,044  Cathepsin H inhibitor
0,155  0,045  Monophenol monooxygenase inhibitor
0,114  0,005  Exportin-1 inhibitor
0,116  0,008  Leukotriene B4 antagonist
0,167  0,059  Antidote
0,113  0,004  Anesthetic inhalation
0,112  0,005  Alpha-mannosidase inhibitor
0,139  0,033  Transcription factor STAT6 inhibitor
0,110  0,005  Mannosidase inhibitor
0,151  0,047  Aldehyde dehydrogenase inhibitor
0,116  0,012  Estrogen-related receptor beta agonist
0,108  0,004  Lysophosphatidic acid 2 receptor antagonist
0,171  0,067  Antihelmintic (Nematodes)
0,205  0,102  Heart failure treatment
0,128  0,024  Antibiotic
0,118  0,016  Hyperparathyroidism treatment
0,140  0,038  TRPA1 agonist
0,110  0,008  Beta 1 adrenoreceptor antagonist
0,105  0,004  Lysophosphatidic acid 3 receptor antagonist
0,132  0,031  Prolactin inhibitor
0,141  0,040  Alcohol dehydrogenase substrate
0,118  0,017  Granulocyte macrophage colony stimulating factor agonist
0,115  0,014  Glycine receptor agonist
0,122  0,023  Restless leg syndrome treatment
0,147  0,048  Proteasome inhibitor
0,122  0,023  Phosphodiesterase 6D inhibitor
0,111  0,012  Alpha 2 adrenoreceptor agonist
0,106  0,007  Glucosylceramidase inhibitor
0,267  0,169  Analgesic
0,224  0,127  CYP2D6 inhibitor
0,105  0,008  Oleamide hydrolase inhibitor
0,116  0,019  Interferon agonist
0,188  0,092  Anticonvulsant
0,110  0,014  Anticholelithogenic
0,118  0,022  Bile acid receptor antagonist
0,144  0,048  Acetylcholine muscarinic antagonist
0,102  0,006  Potassium channel (Inward rectifier) blocker
0,150  0,054  Nav1.6 sodium channel blocker
0,114  0,019  Sphingosine 1-phosphate receptor 4 agonist
0,111  0,016  Carbonic anhydrase stimulant
0,102  0,008  SULT2A1 substrate
0,114  0,020  Na+ K+ transporting ATPase inhibitor
0,098  0,004  Alpha 1d adrenoreceptor agonist
0,148  0,054  Toll-Like receptor 2 antagonist
0,107  0,013  Neuraminidase inhibitor
0,139  0,045  Antiviral (Papilloma)
0,157  0,063  Thiol protease inhibitor
0,097  0,004  Pregnane X receptor antagonist
0,176  0,083  Antihelmintic
0,105  0,013  Endocannabinoid uptake inhibitor
0,213  0,121  Transcription factor STAT inhibitor
0,117  0,025  Bromodomain-containing protein 2 inhibitor
0,151  0,060  Sphingosine 1-phosphate receptor 5 antagonist
0,109  0,019  SULT1A2 substrate
0,120  0,030  Antifungal (Aspergillus)
0,095  0,008  Beta 2 adrenoreceptor antagonist
0,155  0,068  CF transmembrane conductance regulator agonist
0,161  0,075  Prostate disorders treatment
0,095  0,009  Antihemophilic
0,092  0,005  Prostaglandin agonist
0,116  0,031  Antiviral (Rhinovirus)
0,098  0,013  Antimycoplasmal
0,153  0,068  Hearing loss treatment
0,097  0,013  Glutamate (mGluR7) antagonist
0,106  0,022  D-Ala-D-Ala ligase inhibitor
0,097  0,014  Interferon inducer
0,109  0,025  Glycine receptor antagonist
0,157  0,073  Neuropathy treatment
0,086  0,005  Diamine oxidase inhibitor
0,084  0,003  Alpha 2a adrenoreceptor agonist
0,087  0,007  Glucose-6-phosphate isomerase inhibitor
0,130  0,050  Alpha 2b adrenoreceptor antagonist
0,143  0,064  Heat shock protein 70 antagonist
0,096  0,017  NMDA 2C receptor antagonist
0,085  0,007  Beta 2 adrenoreceptor agonist
0,087  0,008  Somatostatin 1 antagonist
0,097  0,020  NMDA receptor agonist
0,108  0,031  Antileprosy
0,093  0,017  Androgen agonist
0,114  0,039  NMDA receptor antagonist
0,135  0,060  M18 aspartyl aminopeptidase inhibitor
0,138  0,064  Skin whitener
0,180  0,107  Potassium channel blocker
0,100  0,027  GABA aminotransferase inhibitor
0,134  0,062  Cholinergic antagonist
0,082  0,010  Dihydroorotate oxidase inhibitor
0,138  0,066  Nav1.2 sodium channel blocker
0,093  0,022  Secretase beta inhibitor
0,202  0,131  Transcription factor STAT3 inhibitor
0,147  0,077  Insulin secretagoues
0,091  0,022  S-adenosyl-L-methionine decarboxylase inhibitor
0,090  0,022  Phospholipase D inhibitor
0,076  0,007  Fumarate hydratase inhibitor
0,092  0,024  Vanilloid 4 agonist
0,072  0,004  Methionyl aminopeptidase 1 inhibitor
0,166  0,098  Antimigraine
0,106  0,039  Aminoacyl-tRNA synthetase inhibitor
0,141  0,074  Lipid peroxidase inhibitor
0,073  0,006  Membrane dipeptidase inhibitor
0,129  0,063  Acetylcholine antagonist
0,070  0,004  Sodium/glucose cotransporter 2 inhibitor
0,075  0,009  Somatostatin 5 antagonist
0,119  0,053  Protein kinase C gamma inhibitor
0,071  0,005  Glucagon receptor antagonist
0,131  0,065  Vanilloid 1 agonist
0,106  0,041  Phosphodiesterase IV inhibitor
0,093  0,027  Sphingosine 1-phosphate receptor antagonist
0,155  0,089  Antipruritic
0,082  0,016  Andropause treatment
0,081  0,016  Sphingosine 1-phosphate receptor 3 antagonist
0,086  0,022  Acetylcholine M5 receptor antagonist
0,136  0,072  Antieczematic
0,136  0,072  Farnesoid X receptor antagonist
0,146  0,083  Hexokinase inhibitor
0,191  0,128  Cardiotonic
0,093  0,032  Estrogen receptor alpha antagonist
0,086  0,026  Peroxisome proliferator-activated receptor gamma antagonist
0,153  0,093  Neurotensin receptor agonist
0,068  0,008  Cytokine production stimulant
0,077  0,017  Sphingosine kinase 2 inhibitor
0,077  0,018  Phosphorylase inhibitor
0,063  0,004  Ceramide glucosyltransferase inhibitor
0,087  0,028  Antitreponemal
0,080  0,021  Ornithine carbamoyltransferase inhibitor
0,116  0,057  Neutropenia treatment
0,063  0,005  Heme oxygenase inhibitor
0,124  0,066  Sphingosine 1-phosphate receptor 4 antagonist
0,124  0,066  DNA repair enzyme inhibitor
0,063  0,005  Prostaglandin E2 agonist
0,093  0,037  Nicotinic alpha4beta2 receptor antagonist
0,060  0,005  Purinergic P2Y14 antagonist
0,062  0,007  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,074  0,019  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,058  0,003  Lysophosphatidic acid receptor 1 agonist
0,071  0,016  Antiviral (Herpesvirus 3, Human)
0,141  0,086  Antiviral (Herpes)
0,105  0,050  MAP kinase kinase 1 inhibitor
0,155  0,101  Toxic, respiratory center
0,080  0,025  Antidote, heavy metal
0,063  0,009  Guanylate cyclase inhibitor
0,071  0,017  Sphingosine 1-phosphate receptor 1 antagonist
0,059  0,006  Liver X receptor beta antagonist
0,075  0,022  NMDA 2A receptor antagonist
0,061  0,008  Beta adrenoreceptor agonist
0,181  0,128  Vascular (periferal) disease treatment
0,079  0,026  Acetylcholine M3 receptor antagonist
0,059  0,007  Kainate receptor agonist
0,058  0,006  Cholesterol absorption inhibitor
0,063  0,011  Dopamine D5 agonist
0,148  0,096  Nitric oxide antagonist
0,094  0,043  Glutathione S-transferase inhibitor
0,146  0,095  Antiviral (Hepatitis C)
0,090  0,039  Antiviral (Dengue virus)
0,062  0,011  Somatostatin 2 antagonist
0,055  0,004  Tryptophan 5 hydroxylase inhibitor
0,066  0,015  NMDA receptor subunit 3A antagonist
0,056  0,006  Prostaglandin D2 agonist
0,085  0,034  MAP kinase kinase 7 inhibitor
0,108  0,059  Beta glucuronidase inhibitor
0,054  0,005  Sodium/glucose cotransporter inhibitor
0,053  0,004  Lysophosphatidic acid 1 receptor antagonist
0,052  0,004  Nicotinic acid receptor 2 antagonist
0,156  0,108  P-glycoprotein inhibitor
0,053  0,005  Cholesterol ester transfer protein antagonist
0,064  0,017  Immunoglobulin Fc receptor antagonist
0,050  0,003  1,3-Beta-glucan synthase inhibitor
0,087  0,039  NMDA 2 receptor antagonist
0,052  0,005  Prostaglandin EP4 agonist
0,106  0,060  Toll-Like receptor 4 antagonist
0,056  0,010  Angiotensin AT1 receptor antagonist
0,060  0,014  Retinoid X receptor agonist
0,092  0,045  Carbonic anhydrase VI inhibitor
0,128  0,083  Neurotrophic factor
0,090  0,045  Glutamate receptor agonist
0,052  0,006  Leukotriene B4 receptor 1 antagonist
0,089  0,044  Carbonic anhydrase XIII inhibitor
0,119  0,075  Nav1.3 sodium channel blocker
0,080  0,035  Potassium channel (Tandem pore domain) blocker
0,150  0,105  Lipocortins synthesis antagonist
0,071  0,027  Calcium channel P-type blocker
0,067  0,023  Thromboxane A2 antagonist
0,060  0,017  Adenylate cyclase 1 inhibitor
0,052  0,010  Glutamate (mGluR8) agonist
0,048  0,006  Prostaglandin EP2 agonist
0,054  0,013  Phosphoglycerate kinase inhibitor
0,057  0,015  Urate transporter 1 inhibitor
0,050  0,008  Uridine phosphorylase inhibitor
0,068  0,027  Thromboxane antagonist
0,153  0,112  Pyruvate kinase inhibitor
0,066  0,026  Postcoital contraceptive
0,074  0,034  Potassium channel (ATP-sensitive) blocker
0,079  0,039  Amidase inhibitor
0,043  0,003  Lysophosphatidic acid receptor 3 agonist
0,043  0,004  Alpha 2b adrenoreceptor agonist
0,053  0,013  Vascular adhesion protein 1 inhibitor
0,057  0,017  Growth hormone release inhibitor
0,077  0,038  Bulimia treatment
0,046  0,008  Kynurenine 3 monooxygenase inhibitor
0,063  0,024  Thromboxane synthase inhibitor
0,056  0,017  Geranyltranstransferase inhibitor
0,096  0,057  Alcohol dehydrogenase inhibitor
0,062  0,024  Leukotriene C antagonist
0,055  0,017  Neurokinin 1 antagonist
0,047  0,009  Angiotensin II receptor antagonist
0,115  0,077  Antiprotozoal (Amoeba)
0,120  0,083  Antihelmintic (Trematoda)
0,091  0,054  Alpha 2 adrenoreceptor antagonist
0,072  0,035  Antiemphysemic
0,121  0,084  Antihemorrhagic
0,054  0,017  5-Alpha-reductase inhibitor
0,111  0,074  Caspase 3 inhibitor
0,076  0,040  Leukotriene synthesis inhibitor
0,084  0,047  Macrophage migration inhibitory factor inhibitor
0,151  0,114  Antiviral (Influenza)
0,051  0,015  GABA uptake inhibitor
0,053  0,017  Liver X receptor alpha agonist
0,042  0,006  Purinergic P2Y15 antagonist
0,066  0,030  Sphingosine kinase inhibitor
0,054  0,019  Erythropoietin receptor agonist
0,127  0,093  Cytidine deaminase inhibitor
0,042  0,008  Somatostatin 4 antagonist
0,038  0,005  Vesicular acetylcholine transporter inhibitor
0,070  0,036  NMDA receptor glycine site agonist
0,039  0,005  Sodium/glucose cotransporter 1 inhibitor
0,052  0,019  Glutamate (mGluR1a) antagonist
0,036  0,004  Vesicular glutamate transport inhibitor
0,050  0,018  Progesterone antagonist
0,058  0,026  Glycine transporter inhibitor
0,070  0,038  Aryl hydrocarbon receptor antagonist
0,037  0,005  Leukotriene B4 receptor 2 antagonist
0,056  0,024  Adenosine deaminase inhibitor
0,054  0,023  Dopamine beta hydroxylase inhibitor
0,052  0,021  Neuraminidase (Influenza A) inhibitor
0,048  0,017  TRPM8 blocker
0,095  0,064  Interleukin 1 beta converting enzyme inhibitor
0,047  0,016  Nicotinic acid receptor agonist
0,063  0,033  Maillard reaction inhibitor
0,043  0,013  Liver X receptor beta agonist
0,037  0,007  Estrogen-related receptor gamma antagonist
0,090  0,061  Polo-like kinase-1 inhibitor
0,074  0,046  Benzodiazepine agonist
0,052  0,024  NMDA receptor subunit 3B antagonist
0,153  0,126  Focal adhesion kinase 2 inhibitor
0,044  0,017  CF transmembrane conductance regulator antagonist
0,032  0,005  Ileal bile acid transport inhibitor
0,054  0,027  Squalene epoxidase inhibitor
0,121  0,094  Psychosexual dysfunction treatment
0,077  0,051  CYP2A6 inhibitor
0,031  0,004  Neuraminidase (Influenza B) inhibitor
0,162  0,136  Antiviral (HIV)
0,069  0,042  MDM2 inhibitor
0,037  0,011  Liver X receptor alpha antagonist
0,031  0,005  Alpha 2c adrenoreceptor agonist
0,052  0,026  Cholesterol esterase inhibitor
0,046  0,021  Hypogonadism treatment
0,082  0,057  CC chemokine 5 receptor agonist
0,033  0,008  Prostaglandin F2 alpha agonist
0,046  0,022  Thymidine kinase inhibitor
0,061  0,036  Botulinum neurotoxin type A inhibitor
0,034  0,009  Thyroid hormone agonist
0,172  0,148  Antiprotozoal (Trypanosoma)
0,054  0,029  Proto-oncogene tyrosine-protein kinase Met inhibitor
0,061  0,037  Dopamine uptake inhibitor
0,032  0,008  Acid ceramidase inhibitor
0,053  0,029  Topoisomerase II beta inhibitor
0,050  0,026  Complement C3a chemotactic receptor antagonist
0,053  0,030  Peroxisome proliferator-activated receptor alpha agonist
0,077  0,053  NAD(P)H dehydrogenase (quinone) inhibitor
0,062  0,038  Cathepsin E inhibitor
0,069  0,045  Phosphodiesterase 4B inhibitor
0,032  0,008  Vanilloid 2 agonist
0,097  0,074  Mediator release inhibitor
0,060  0,037  Ryanodine receptor antagonist
0,038  0,015  GABA transporter 3 inhibitor
0,125  0,102  Antianemic
0,027  0,004  Antibiotic Anthracycline-like
0,070  0,049  Peroxisome proliferator-activated receptor gamma agonist
0,058  0,037  Carbonic anhydrase VB inhibitor
0,037  0,016  Liver X receptor antagonist
0,081  0,060  Inducible nitric-oxide synthase inhibitor
0,031  0,010  Hedgehog signaling activator
0,045  0,025  Sphingosine 1-phosphate receptor 1 agonist
0,062  0,042  Narcolepsy treatment
0,043  0,023  Substance P antagonist
0,036  0,015  Glutamate (mGluR3) agonist
0,052  0,032  Potassium channel (Inward rectifier) activator
0,040  0,020  Retinoid X alpha receptor agonist
0,053  0,033  Diacylglycerol O-acyltransferase inhibitor
0,033  0,013  Prostaglandin EP4 antagonist
0,052  0,032  Neurokinin antagonist
0,040  0,021  Glutamate (mGluR3) antagonist
0,041  0,022  Leukotriene C4 antagonist
0,058  0,039  Alpha 1 adrenoreceptor agonist
0,049  0,031  Potassium channel (ATP-sensitive) activator
0,086  0,067  Potassium channel activator
0,043  0,025  Sphingosine kinase 1 inhibitor
0,062  0,043  Acetylcholine M2 receptor antagonist
0,082  0,064  Histamine N-methyltransferase inhibitor
0,028  0,010  Beta 1 adrenoreceptor agonist
0,185  0,168  12-Lipoxygenase inhibitor
0,110  0,093  Antismoking
0,020  0,003  Antibiotic beta Lactam-like
0,026  0,010  5-Alpha-reductase 2 inhibitor
0,136  0,120  Sleep disorders treatment
0,025  0,009  Imidazoline I1 receptor antagonist
0,039  0,023  Vanilloid 3 antagonist
0,022  0,006  Telomerase stimulant
0,048  0,032  Benzodiazepine antagonist
0,100  0,085  Nav1.5 sodium channel blocker
0,091  0,075  Tourette's syndrome treatment
0,033  0,018  Cyclophilin A inhibitor
0,039  0,024  Retinoid X receptor antagonist
0,044  0,029  Glutamate (mGluR group III) antagonist
0,141  0,125  LDLR expression enhancer
0,024  0,009  Antibiotic Quinolone-like
0,019  0,004  Thromboxane agonist
0,031  0,017  Potassium channel (Inward rectifier) 1 blocker
0,035  0,021  Free fatty acid receptor 1 antagonist
0,050  0,036  Alpha 1b adrenoreceptor agonist
0,060  0,046  Prostaglandin F2 alpha antagonist
0,025  0,011  Retinoic acid gamma receptor agonist
0,102  0,088  MAO inhibitor
0,092  0,078  Falcipain 3 inhibitor
0,016  0,002  Antibiotic Penem-like
0,035  0,022  Retinoid X alpha receptor antagonist
0,023  0,009  Factor IX inhibitor
0,033  0,020  Nucleoside transporters inhibitor
0,088  0,075  Xanthine oxidase inhibitor
0,024  0,011  Somatostatin 3 antagonist
0,023  0,010  Retinoid X beta receptor antagonist
0,020  0,008  Methylmalonyl-CoA mutase inhibitor
0,126  0,114  Macular degeneration treatment
0,016  0,004  Immunosuppressant Cyclosporine-like
0,019  0,007  Vitamin D receptor agonist
0,086  0,075  5-Lipoxygenase inhibitor
0,033  0,021  ATP citrate lysase inhibitor
0,035  0,023  Calcitonin receptor agonist
0,083  0,071  ATPase (Vacuolar H+) inhibitor
0,053  0,041  Epithelial sodium channel blocker
0,024  0,013  Glutamate (mGluR1a) agonist
0,025  0,013  Alpha 1a adrenoreceptor agonist
0,021  0,010  5-Alpha-reductase 1 inhibitor
0,024  0,013  GRP78 expression inhibitor
0,027  0,016  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,122  0,111  Hemostatic
0,036  0,026  Inosine monophosphate dehydrogenase inhibitor
0,137  0,126  3C-like protease (Human coronavirus) inhibitor
0,019  0,008  Tryptophan hydroxylase 1 inhibitor
0,150  0,141  Growth factor agonist
0,050  0,041  Toll-Like receptor 8 antagonist
0,066  0,056  Protein kinase C beta inhibitor
0,100  0,091  Aldehyde dehydrogenase substrate
0,026  0,017  Methionyl aminopeptidase 2 inhibitor
0,038  0,029  5 Hydroxytryptamine 2B agonist
0,017  0,009  Thromboxane A2 agonist
0,018  0,010  Carbonic anhydrase VIII inhibitor
0,018  0,010  Carbonic anhydrase X inhibitor
0,140  0,132  Antiviral (Hepatitis)
0,038  0,030  Retinoic acid alpha receptor agonist
0,021  0,013  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,033  0,026  Somatostatin 5 agonist
0,042  0,035  Purinergic P2Y antagonist
0,061  0,053  Transcription factor RelA inhibitor
0,021  0,014  GABA transporter inhibitor
0,012  0,005  CD80 antagonist
0,012  0,006  Imidazoline I2 receptor antagonist
0,041  0,035  Sphingosine 1-phosphate receptor agonist
0,022  0,016  Isoleucine-tRNA ligase inhibitor
0,041  0,034  GABA B receptor antagonist
0,038  0,031  Toll-Like receptor 2 agonist
0,020  0,014  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,019  0,013  Apical sodium codependent bile acid transporter inhibitor
0,059  0,054  Protease 3C (Human rhinovirus) inhibitor
0,126  0,120  Pulmonary hypertension treatment
0,059  0,055  Carbonic anhydrase V inhibitor
0,042  0,038  Thymidylate synthase inhibitor
0,016  0,012  Adenosine A2 receptor agonist
0,041  0,037  Dihydroorotase inhibitor
0,111  0,107  Papain-like protease (SARS coronavirus) inhibitor
0,020  0,016  Excitatory amino acid transporter 3 inhibitor
0,071  0,067  Acetylcholine nicotinic antagonist
0,022  0,018  Retinoic acid receptor agonist
0,039  0,035  Glutamate (mGluR group III) agonist
0,053  0,049  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,039  0,037  Nerve growth factor antagonist
0,015  0,012  GABA transporter 1 inhibitor
0,025  0,022  Hypoxanthine phosphoribosyltransferase inhibitor
0,040  0,038  AICAR transformylase inhibitor
0,013  0,011  Proline transporter inhibitor
0,037  0,035  Oxytocin agonist
0,016  0,014  Nicotinic acid receptor 1 antagonist
0,011  0,009  Beta 3 adrenoreceptor agonist
0,008  0,006  Thyroid hormone beta agonist
0,003  0,001  Antibiotic Tribactam-like
0,081  0,079  MAO A inhibitor
0,011  0,009  Glutamate (mGluR6) agonist
0,049  0,047  Nicotinic alpha3beta2 receptor antagonist
0,013  0,011  Angiotensin AT1B receptor antagonist
0,135  0,133  Antiarrhythmic
0,010  0,009  Calcineurin inhibitor
0,022  0,021  Prostaglandin H2 antagonist
0,017  0,016  Estrogen-related receptor gamma agonist
0,014  0,012  Adenosine A2a receptor agonist
0,043  0,041  CC chemokine 4 receptor antagonist
0,033  0,032  Farnesoid X receptor agonist
0,018  0,017  Caspase 8 inhibitor
0,012  0,011  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,035  0,034  Vesicle monoamine transporter inhibitor
0,004  0,003  Antibiotic Carbapenem-like
0,018  0,018  Follicle-stimulating hormone antagonist
0,060  0,060  Carbonic anhydrase VA inhibitor
0,100  0,099  Estrogen antagonist
0,014  0,014  Purinergic P2Y1 agonist
0,117  0,117  Restenosis treatment
0,045  0,045  Neuropeptide agonist

